MASI

Masimo Corporation

Technology · Electromedical & Electrotherapeutic Apparatus
$0.00+0.00% today
AI Take · AlgoThesis

Masimo's RSI of 66.8 places it firmly in overbought territory, yet the stock remains 12.4% below its 52-week high—a disconnect suggesting unfinished upside momentum or vulnerability to mean reversion. With a market cap of $9.3B and 8.01% short interest, the company sits between meme-stock territory and institutional positioning. The absence of a P/E ratio raises questions about profitability or valuation methodology, which combined with elevated technicals, implies either a narrative-driven run lacking fundamental anchors or significant operational challenges masking the rally. This setup carries squeeze potential if sentiment shifts suddenly.

Snapshot

Market cap
$9.3B
P/E
Forward P/E
29.1
EPS (TTM)
$-2.77
Dividend yield
Net margin
-9.9%
ROE
-17.2%
RSI (14)
67
Beta
0.60
Short % of float
8.0%
Days to cover
2.7
52w high
No

Recent headlines

Peers in Electromedical & Electrotherapeutic Apparatus

Build a thesis around MASI

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →